BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28422438)

  • 1. Moyamoya syndrome in children with neurofibromatosis type 1: Italian-French experience.
    Santoro C; Di Rocco F; Kossorotoff M; Zerah M; Boddaert N; Calmon R; Vidaud D; Cirillo M; Cinalli G; Mirone G; Giugliano T; Piluso G; D'Amico A; Capra V; Pavanello M; Cama A; Nobili B; Lyonnet S; Perrotta S
    Am J Med Genet A; 2017 Jun; 173(6):1521-1530. PubMed ID: 28422438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct Clinical and Radiographic Phenotypes in Pediatric Patients With Moyamoya.
    Kaseka ML; Slim M; Muthusami P; Dirks PB; Westmacott R; Kassner A; Bhathal I; Williams S; Shroff M; Logan W; Moharir M; MacGregor DL; Pulcine E; deVeber GA; Dlamini N
    Pediatr Neurol; 2021 Jul; 120():18-26. PubMed ID: 33962345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of Moyamoya Syndrome in Pediatric Patients With Neurofibromatosis Type 1.
    Brosius SN; Vossough A; Fisher MJ; Lang SS; Beslow LA; George BJ; Ichord R
    Pediatr Neurol; 2022 Sep; 134():85-92. PubMed ID: 35849956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical Treatment for Patients with Moyamoya Syndrome and Type 1 Neurofibromatosis.
    Porras JL; Yang W; Garzon-Muvdi T; Xu R; Blakeley J; Belzberg A; Caplan JM; Khalid S; Colby GP; Coon AL; Tamargo RJ; Ahn ES; Huang J
    World Neurosurg; 2017 Mar; 99():19-25. PubMed ID: 27876659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole exome sequencing identifies MRVI1 as a susceptibility gene for moyamoya syndrome in neurofibromatosis type 1.
    Santoro C; Giugliano T; Kraemer M; Torella A; Schwitalla JC; Cirillo M; Melis D; Berlit P; Nigro V; Perrotta S; Piluso G
    PLoS One; 2018; 13(7):e0200446. PubMed ID: 30001348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and long-term outcomes of moyamoya syndrome associated with neurofibromatosis type 1.
    Han C; Yang WZ; Zhang HT; Ye T; Duan L
    J Clin Neurosci; 2015 Feb; 22(2):286-90. PubMed ID: 25443089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between moyamoya syndrome and the RNF213 c.14576G>A variant in patients with neurofibromatosis Type 1.
    Phi JH; Choi JW; Seong MW; Kim T; Moon YJ; Lee J; Koh EJ; Ryu SK; Kang TH; Bang JS; Oh CW; Park SS; Lee JY; Wang KC; Kim SK
    J Neurosurg Pediatr; 2016 Jun; 17(6):717-22. PubMed ID: 26849809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal evaluation of the cerebrovascular reserve in Neurofibromatosis type 1 patients with Moyamoya syndrome.
    D'Amico A; Ugga L; Cocozza S; Giorgio SMDA; Cicala D; Santoro C; Melis D; Cinalli G; Brunetti A; Pappatà S
    Neurol Sci; 2021 Feb; 42(2):655-663. PubMed ID: 32651859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel NF1 deletion variant in a Taiwanese boy with neurofibromatosis type 1-associated Moyamoya syndrome.
    Yang YY; Yu CH; Hu CF; Sung CC; Chen SJ
    Pediatr Neonatol; 2023 Mar; 64(2):210-212. PubMed ID: 36529650
    [No Abstract]   [Full Text] [Related]  

  • 10. 'Moya' than meets the eye: neurofibromatosis type 1 associated with Moyamoya syndrome.
    Tan RM; Chng SM; Seow WT; Wong J; Lim CC
    Singapore Med J; 2008 Apr; 49(4):e107-9. PubMed ID: 18418511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotype-Genotype Correlation in Children with Neurofibromatosis Type 1.
    Barrea C; Vaessen S; Bulk S; Harvengt J; Misson JP
    Neuropediatrics; 2018 Jun; 49(3):180-184. PubMed ID: 29471550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical revascularization as a procedure to prevent neurological complications in children with moyamoya syndrome associated with neurofibromatosis I: a single institution case series.
    Morello A; Scala M; Schiavetti I; Diana MC; Severino M; Tortora D; Piatelli G; Pavanello M
    Childs Nerv Syst; 2024 Jun; 40(6):1731-1741. PubMed ID: 38316674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic hypertension followed by insidious stroke in a 12-year-old boy with childhood neurofibromatosis type 1 presenting with renal and cerebral artery vasculopathy.
    Lee ML; Chang TM; Yang RC; Yang AD; Chen M
    Turk J Pediatr; 2019; 61(4):629-634. PubMed ID: 31990487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seizures in children with neurofibromatosis type 1: is neurofibromatosis type 1 enough?
    Santoro C; Bernardo P; Coppola A; Pugliese U; Cirillo M; Giugliano T; Piluso G; Cinalli G; Striano S; Bravaccio C; Perrotta S
    Ital J Pediatr; 2018 Mar; 44(1):41. PubMed ID: 29566708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization.
    Koss M; Scott RM; Irons MB; Smith ER; Ullrich NJ
    J Neurosurg Pediatr; 2013 Apr; 11(4):417-25. PubMed ID: 23373626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofibromatosis type 1 associated with moyamoya syndrome in children.
    Duat-Rodríguez A; Carceller Lechón F; López Pino MÁ; Rodríguez Fernández C; González-Gutiérrez-Solana L
    Pediatr Neurol; 2014 Jan; 50(1):96-8. PubMed ID: 24269170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moyamoya syndrome in a child with Legius syndrome: Introducing a cerebral vasculopathy to the SPRED1 phenotype?
    Pabst L; Carroll J; Lo W; Truxal KV
    Am J Med Genet A; 2021 Jan; 185(1):223-227. PubMed ID: 33078527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moyamoya syndrome and neurofibromatosis type 1.
    Vargiami E; Sapountzi E; Samakovitis D; Batzios S; Kyriazi M; Anastasiou A; Zafeiriou DI
    Ital J Pediatr; 2014 Jun; 40():59. PubMed ID: 24952383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions.
    Mautner VF; Kluwe L; Friedrich RE; Roehl AC; Bammert S; Högel J; Spöri H; Cooper DN; Kehrer-Sawatzki H
    J Med Genet; 2010 Sep; 47(9):623-30. PubMed ID: 20543202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moyamoya Vasculopathy in Neurofibromatosis Type 1 Pediatric Patients: The Role of Rare Variants of
    Ognibene M; Scala M; Iacomino M; Schiavetti I; Madia F; Traverso M; Guerrisi S; Di Duca M; Caroli F; Baldassari S; Tappino B; Romano F; Uva P; Vozzi D; Chelleri C; Piatelli G; Diana MC; Zara F; Capra V; Pavanello M; De Marco P
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.